NCT00647114 A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00646945 Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology Status COMPLETED Phase PHASE4
NCT00644787 A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain Status COMPLETED Phase PHASE2/PHASE3
NCT00641667 An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain Status COMPLETED Phase PHASE3
NCT00637975 Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain Status COMPLETED Phase PHASE2
NCT00637637 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Status UNKNOWN Phase PHASE2
NCT00635063 A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects Status TERMINATED Phase PHASE3
NCT00632398 Multimedia Training for Family Caregivers in Use of Touch and Massage in Supportive Cancer Care Status COMPLETED Phase PHASE2
NCT00630110 Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00627029 Evaluation of Programs of Coordinated Care and Disease Management Status UNKNOWN Phase NA
NCT00624312 Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations Status WITHDRAWN Phase PHASE2
NCT00622063 An Extension Study for Patients Previously Treated With ARQ 501 Status COMPLETED Phase PHASE1/PHASE2
NCT00617929 Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant Status TERMINATED Phase PHASE2
NCT00617253 Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients Status COMPLETED Phase PHASE2
NCT00615147 Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population Status COMPLETED Phase N/A